Parenteral Succinate Reduces Systemic ROS Production in Septic Rats, but It Does Not Reduce Creatinine Levels

Area of Science:

• Biochemistry
• Physiology
• Pathology

Background:

• Sepsis is characterized by increased reactive oxygen species (ROS) production, primarily in the electron transport chain.
• ROS contributes to multiple organ failure during sepsis.
• Succinate supplementation offers a potential therapeutic strategy by influencing electron transport chain dynamics.

Purpose of the Study:

• To investigate the effect of parenteral succinate on systemic ROS production in a sepsis model.
• To evaluate whether succinate administration improves kidney function in septic rats.
• To determine the correlation between systemic ROS levels and kidney function markers.

Main Methods:

• A cecal ligation and puncture (CLP) rat model was used to induce sepsis.
• Four experimental groups were established: Control, Succinate-only, Sepsis-only, and Sepsis with Succinate treatment.
• Systemic ROS levels and serum creatinine were measured 24 hours post-CLP.

Main Results:

• Septic rats treated with parenteral succinate exhibited significantly reduced systemic ROS levels compared to untreated septic rats (p = 0.007).
• No significant difference in creatinine levels was observed between the Sepsis and Sepsis with Succinate groups (p = 0.07).
• A lack of correlation was found between systemic ROS levels and creatinine levels (p = 0.3).

Conclusions:

• Parenteral succinate effectively reduces systemic ROS production in a sepsis model.
• Succinate administration does not improve kidney function markers, such as creatinine levels, in this model.
• The reduction in ROS and the lack of improvement in kidney function suggest that these processes are not directly linked in sepsis pathophysiology.